A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Ivermectin Photolytic degradation impurity-2 (aldehyde impurity) | Ivermectin Photolytic degradation impurity-2 (aldehyde impurity) is a degradation impurity of Ivermectin, an antiparasitic drug that is active against a wide variety of nematode and arthropod parasites and is used to treat scabies and lice in humans. Synonyms: (2R,2a'Z,4'E,5S,6R,6'S,7'S,8'E,11'R, 15'S, 17a'R,20'R,20a'S)-6-((S)-sec-butyl)-20'-hydroxy-7'-(((2R,4S,5S,6S)-5-(((2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-methoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-5,6',8',19'-tetramethyl-17'-oxo-2a1',3,4,5,6,6',10',11',14',15',17',17a',20',20a'-tetra decahydro-2'H,7'H-spir[pyran-2,13'-[11,15]methano[1,5]dioxacyclooctadecino[9,8,7-cd]benzofuran]-2'-carbaldehyde. |  |
| Ivermectin USP | Ivermectin USP. |  CA, FL & NJ |
| Ivicentamab | Ivicentamab (GEN-3009) is a bispecific antibody targeting CD37 with dual epitopes. Ivicentamab carries an E430G mutation in the Fc region, which efficiently promotes IgG hexamer formation on the surface of target cells. Ivicentamab provides the parental variable regions for an H429F-engineered anti-CD37 bispecific antibody, enabling it to exert complement-dependent cytotoxicity in Daudi lymphoma cells. Ivicentamab is mainly used in lymphoma-related research[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: GEN-3009. CAS No. 2364496-42-2. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99674. |  |
| Ivonescimab | Ivonescimab (AK112) is a PD-1/VEGF bispecific antibody. Ivonescimab competitively inhibiting PD-1/PD-L1 interaction, reversing the immunosuppression mediated by it, and blocks the binding of VEGF-A to VEGFR2, inhibiting tumour angiogenesis in the tumour microenvironment. Ivonescimab also has significantly anticancer activity against EGFR-mutated locally advanced or metastatic non-squamous non-small cell lung cancer (NSCL)[1][2][3][4][5]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: AK112. CAS No. 2428381-53-5. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-P99675. | |
| Ivosidenib | Ivosidenib (AG-120) is an orally active inhibitor of isocitrate dehydrogenase 1 mutant (mIDH1) enzyme, it exhibits profound d-2-hydroxyglutatrate (2-HG) lowering in vivo. Ivosidenib (AG-120) has the potential for AML therapy due to its acceptable safety profile and clinical activity[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: AG-120. CAS No. 1448347-49-6. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-18767. | |
| Ivosidenib | Ivosidenib (AG-120) is an orally available inhibitor of isocitrate dehydrogenase type 1 (IDH1) with potential antineoplastic activity. It specifically inhibits a mutated form of IDH1 in the cytoplasm, preventing the formation of the oncometabolite 2-hydroxyglutarate (2 hG), which may induce cellular differentiation and inhibit cellular proliferation in IDH1-expressing tumor cells. Category: Active pharmaceutical ingredients. Grades: USDMF. CAS No. 1448347-49-6. Product ID: API1448347496. Molecular formula: C28H22ClF3N6O3. Mole weight: 582.96. Standard: GMP. |  |
| Ivospemin | Ivospemin (SBP-101) is an antineoplastic spermine analog. Ivospemin has shown efficacy in slowing pancreatic and ovarian tumor progression in vitro and in vivo. Ivospemin shows modest induction of polyamine catabolism, but stronger repression of ornithine decarboxylase activity. Ivospemin is promising for research of cancers[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: SBP-101. CAS No. 748119-79-1. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-132822. | |
| IVQRFKDFRNLVRLIK | IVQRFKDFRNLVRLIK. Synonyms: Ile-Val-Gln-Arg-Phe-Lys-Asp-Phe-Arg-Asn-Leu-Val-Arg-Leu-Ile-Lys. Molecular formula: C95H161N29O21. Mole weight: 2045.52. | |
| Ivuxolimab | Ivuxolimab is a fully human IgG2 agonist targeting OX40 (CD134), which selectively binds to the OX40 receptor on the surface of activated CD4+ and CD8+ T cells without inducing antibody-dependent cytotoxicity. Ivuxolimab can promote T cell proliferation, survival and cytokine (such as IFN-γ, IL-2) secretion, inhibit regulatory T cell function, and enhance anti-tumor immune response. Ivuxolimab can be used in the study of melanoma, hepatocellular carcinoma, head and neck squamous cell carcinoma, etc[1][2][3]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2128729-41-7. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99159. | |
| Ivy Base | Ivy Base. CAS No. MIXTURE. VIGON Item # 504914. Categories: Speciality Ingrdients Suppliers, Fragrances, Perfumers. |  America & Internationally |
| Ivy Extract | Ivy extract is prepared from leaf and stem of araliaceae family plant Hedera nepalensis var. sinensis (tobl.) rehd. Ivy extract is a product that widely used in medicine and cosmetics. Ivy extract has the function of moisturizing skin, and reducing wrinkles on face. Group: Others. Mole weight: 472.7. Ivy Extract; Hedera Nepalensis Var. Sinensis (Tobl.) Rehd. Cat No: EXTC-059. |  |
| Ivy Extract (Hederacoside C) | Ivy Extract (Hederacoside C). CAS No. 84082-54-2. Purity: 5-45%. Product ID: CI-NAT-84082542. Molecular formula: C59H96O26. Mole weight: 1221.38 g/mol. Alfa Chemistry - ISO 9001:32057 Certified. |  |
| Ivy P.E. 4:1 (Hedera helix) | Ivy P.E. 4:1 (Hedera helix). | CA, FL & NJ |
| IWP 12 | IWP 12. Group: Biochemicals. Grades: Purified. CAS No. 688353-45-9. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. |  Worldwide |
| IWP 2 | IWP 2. Group: Biochemicals. Grades: Purified. CAS No. 686770-61-6. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| IWP-2 | IWP-2 is an inhibitor of Wnt processing and secretion with an IC50 of 27 nM. IWP-2 targets the membrane-bound O-acyltransferase porcupine (Porcn) and thus preventing a crucial Wnt ligand palmitoylation. IWP-2 is also an ATP-competitive CK1δ inhibitor with an IC50 of 40 nM for the gatekeeper mutant M82FCK1δ[1][2]. Uses: Scientific research. Category: Signaling pathways. CAS No. 686770-61-6. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-13912. | |
| IWP-2 | IWP-2. Group: Biochemicals. Alternative Names: N-(6-Methyl-2-benzothiazolyl)-2-[(3,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2-d]pyrimidin-2-yl)thio]acetamide. Grades: Highly Purified. CAS No. 686770-61-6. Pack Sizes: 10mg, 25mg, 50mg, 100mg, 250mg. Molecular Formula: C22H18N4O2S3. US Biological Life Sciences. | Worldwide |
| IWP-2 | IWP-2 is an inhibitor of Wnt processing and secretion with IC50 of 27 nM in a cell-free assay, selective blockage of Porcn-mediated Wnt palmitoylation, does not affect Wnt/β-catenin in general and displays no effect against Wnt-stimulated cellular responses. IWP-2 specifically inhibits CK1δ. Group: Inhibitors. CAS No. 686770-61-6. Pack Sizes: 10mg. Product ID: S7085. Formula: C22H18N4O2S3. Smiles: CC1=CC2=C(C=C1)N=C(S2)NC(=O)CSC3=NC4=C(C(=O)N3C5=CC=CC=C5)SCC4. Storage Conditions: 2 years -80 in solvent. |  United States; Europe |
| IWP-3 | IWP-3 is an potent inhibitor of Wnt production with an IC50 of 40 nM. IWP-3 inhibits Porcupine (Porcn) function thereby blocking palmitoylation of Wnt proteins. IWP-3 inhibits CK1γ3 and CK1ε only moderately and does not inhibit CK1α[1][2]. Uses: Scientific research. Category: Signaling pathways. CAS No. 687561-60-0. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-100536. | |
| IWP 4 | IWP 4. Group: Biochemicals. Grades: Purified. CAS No. 686772-17-8. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| IWP-4 | IWP-4 is a Wnt inhibitor with an IC50 of 25 nM. IWP-4 specifically inhibits casein kinase 1δ/ε (CK1δ/ε), with an IC50 of 1.06 μM against wild-type CK1δ, 1.02 μM against the CK1δ kinase domain, and 7.07 μM against CK1ε; it shows enhanced inhibitory activity against the M82F CK1δ mutant (IC50 = 0.14 μM). IWP-4 is applicable to research related to cancer, Alzheimer's disease (AD), and heart failure[1][2][3]. Uses: Scientific research. Category: Signaling pathways. CAS No. 686772-17-8. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-12879. | |
| IWP L6 | IWP L6. Group: Biochemicals. Grades: Purified. CAS No. 1427782-89-5. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| IWP-O1 | IWP-O1 is a highly potent Porcupine (Porcn) inhibitor, with an EC50 of 80 pM in L-Wnt-STF cells. IWP-O1 prevents the secretion of Wnt proteins. IWP-O1 suppresses the phosphorylation of Dvl2/3 and LRP6 in HeLa cells[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2074607-48-8. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-100853. | |
| IWR-1 | IWR-1 (IWR-1-endo) is a tankyrase inhibitor targeting Wnt/β-catenin (IC50 = 180 nM). IWR-1 compromises critical steps of the canonical Wnt signaling, namely translocation of β-catenin to the nucleus and subsequent TCF/LEF activation and expression of Wnt/β-catenin downstream targets. IWR-1 promotes β-catenin phosphorylation by promoting stability of Axin-scaffolded destruction complexes. IWR-1 can be studied in research for anti-tumor purposes, and diseases such as osteosarcoma, colorectal cancer and psoriasis[1][2][4]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: endo-IWR 1; IWR-1-endo. CAS No. 1127442-82-3. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-12238. | |
| IWR-1 | IWR-1. CAS No: 430429-02-0 |  Sarchem Laboratories New Jersey NJ |
| IWR-1-endo | IWR-1-endo (endo-IWR 1, IWR-1) is a Wnt pathway inhibitor with IC50 of 180 nM in L-cells expressing Wnt3A, induces Axin2 protein levels and promotes β-catenin phosphorylation by stabilizing Axin-scaffolded destruction complexes. Group: Inhibitors. Alternative Names: endo-IWR 1, IWR-1. CAS No. 1127442-82-3. Pack Sizes: 10mg. Product ID: S7086. Formula: C25H19N3O3. Smiles: C1C2C=CC1C3C2C(=O)N(C3=O)C4=CC=C(C=C4)C(=O)NC5=CC=CC6=C5N=CC=C6. Storage Conditions: 2 years -80 in solvent. | United States; Europe |
| IWR-1 (IWR-1-endo) | Potent and reversible cell permeable Wnt pathway signaling inhibitor. Inhibits Wnt-induced accumulation of β-catenin, leading to proteasomal degradation of this protein through a destruction complex which consists of Apc, Axin2, CK1 and GSK-3 &beta. Stabilizes the destruction complex, increasing the level of Axin2 protein without changing the levels of Apc or GSK-3 &beta. Tankyrase-1 (TNKS1/PARP5a) and Tankyrase-2 (TNKS2/PARP5b) inhibitor (in vitro auto-PARsylation assay). Group: Biochemicals. Alternative Names: 4-[(3aR,4S,7R,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide. Grades: Highly Purified. CAS No. 1127442-82-3. Pack Sizes: 5mg, 25mg. Molecular Formula: C??H??N?O?, Molecular Weight: 409.4. US Biological Life Sciences. | Worldwide |
| IXA4 | IXA4 is a highly selective, non-toxic IRE1/XBP1s activator. IXA4 activates IRE1/XBP1s signaling without globally activating the unfolded protein response (UPR) or other stress-responsive signaling pathways (e.g., the heat shock response or oxidative stress response). IXA4 reduces secretion of APP through IRE1 activation[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1185329-96-7. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-139214. | |
| IXA6 | IXA6 is a novel IRE1/XBP1s activator, and can induce IRE1 RNase activity[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1021106-40-0. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg. Product ID: HY-139212. | |
| IXA62 | IXA62 is an orally active and selective IRE1/XBP1s activator (EC50 = 0.31 μM) that reduces Aβ secretion. IXA62 enhances glucose-stimulated insulin secretion from rat insulinoma cells[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 956783-34-9. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-176040. | |
| Ixabepilone | Ixabepilone (BMS-247550) is an orally bioavailable microtubule inhibitor, which binds to tubulin and promotes tubulin polymerization and microtubule stabilization, thereby arrests cells in the G2-M phase of the cell cycle and induces tumor cell apoptosis. Uses: Scientific research. Category: Signaling pathways. Alternative Names: BMS-247550; Aza-epothilone B. CAS No. 219989-84-1. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg. Product ID: HY-10222. | |
| Ixaconazole chloride | Ixaconazole chloride. Uses: For analytical and research use. CAS No. 497235-79-7. Molecular formula: C35H36Cl2F2N8O5S. Mole weight: 789.68. Catalog: APB497235797. |  |
| Ixaconazole Impurity31 | Ixaconazole Impurity31. Uses: For analytical and research use. CAS No. 40805-50-3. Molecular formula: C9H6ClNO. Mole weight: 179.6. Catalog: APB40805503. | |
| Ixaconazole-Intermediate 11 (p-cyanoacetophenone) | Ixaconazole-Intermediate 11 (p-cyanoacetophenone). Uses: For analytical and research use. CAS No. 1443-80-7. Molecular formula: C9H7NO. Mole weight: 145.16. Catalog: APB1443807. | |
| Ixaconazole side chain intermediate 2 | Ixaconazole side chain intermediate 2. Uses: For analytical and research use. CAS No. 1180002-01-0. Molecular formula: C15H23N3O4. Mole weight: 309.36. Catalog: APB1180002010. | |
| Ixaconazole side chain intermediate 3 | Ixaconazole side chain intermediate 3. Uses: For analytical and research use. CAS No. 20099-89-2. Molecular formula: C9H6BrNO. Mole weight: 224.05. Catalog: APB20099892. | |
| Ixaconazole side chain intermediate 4 | Ixaconazole side chain intermediate 4. Uses: For analytical and research use. Molecular formula: C14H19CIN2O4. Mole weight: 314.77. Catalog: APB10584. | |
| Ixazomib | Ixazomib (MLN2238) is a selective, potent, and reversible proteasome inhibitor, which inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteasome with an IC50 of 3.4 nM (Ki of 0.93 nM). Uses: Scientific research. Category: Signaling pathways. Alternative Names: MLN2238. CAS No. 1072833-77-2. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-10453. | |
| Ixazomib | ixazomib is an orally bioavailable second generation proteasome inhibitor (PI) with potential antineoplastic activity. Ixazomib inhibits the activity of the proteasome, blocking the targeted proteolysis normally performed by the proteasome, which results in an accumulation of unwanted or misfolded proteins; disruption of various cell signaling pathways may follow, resulting in the induction of apoptosis. Compared to first generation PIs, second generation PIs may have an improved pharmacokinetic profile with increased potency and less toxicity. Proteasomes are large protease complexes that degrade unneeded or damaged proteins that have been ubiquinated. Category: Active pharmaceutical ingredients. Synonyms: 4-(carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid. Ixazomib Citrate (MLN9708). 4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid. CAS No. 1201902-80-8. Product ID: API1201902808. Molecular formula: C20H23BCl2N2O9. Mole weight: 517.1. SMILES: B1(OC(=O)CC(O1)(CC(=O)O)C(=O)O)C(CC(C)C)NC(=O)CNC(=O)C2=C(C=CC(=C2)Cl)Cl. Appearance: White to Off-White Solid. | |
| Ixazomib citrate | Ixazomib citrate (MLN9708) is a selective, orally active, second-generation proteasome inhibitor. Ixazomib citrate can be used for the study of a broad range of human malignancies[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: MLN9708. CAS No. 1239908-20-3. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 250 mg; 500 mg. Product ID: HY-10452. | |
| Ixazomib Citrate | The citrate salt form of Ixazomib which is a proteasome inhibitor. It is undergoing a rollover Phase II trial against multiple myeloma, amyloidosis and lymphoma in sorts of countries. IC50 = 3.4 nM. Synonyms: 4-(carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid; MLN9708; MLN-9708; MLN 9708. Grade: 98%. CAS No. 1239908-20-3. Molecular formula: C20H23BCl2N2O9. Mole weight: 517.12. | |
| Ixazomib Citrate | Ixazomib Citrate. Uses: For analytical and research use. CAS No. 1201902-80-8. Molecular formula: C20H23BCl2N2O9. Mole weight: 517.12. Catalog: APB1201902808. | |
| Ixazomib Impurity 1 | Ixazomib Impurity 1. Uses: For analytical and research use. Alternative Names: (R)-2,2'-(2-(1-(2,5-dichlorobenzamido)-3-methylbutyl)-5-oxo-1,3,2-dioxaborolane-4,4-diyl)diacetic acid. Molecular formula: C18H20BCl2NO8. Mole weight: 460.07. Catalog: APB02180. | |
| Ixazomib Impurity 1 | Ixazomib Impurity 1. Uses: For analytical and research use. CAS No. 1201903-02-7. Molecular formula: C24H33BCl2N2O4. Mole weight: 495.25. Catalog: APB1201903027. | |
| Ixazomib Impurity 10 | Ixazomib Impurity 10. Uses: For analytical and research use. Alternative Names: 2,5-dichloro-N-(2-(3-methylbutanamido)-2-oxoethyl)benzamide. Molecular formula: C14H16Cl2N2O3. Mole weight: 331.19. Catalog: APB02175. | |
| Ixazomib Impurity 11 | Ixazomib Impurity 11. Uses: For analytical and research use. CAS No. 69125-10-6. Molecular formula: C3H2ClN3O2. Mole weight: 147.52. Catalog: APB69125106. | |
| Ixazomib Impurity 12 | Ixazomib Impurity 12. Uses: For analytical and research use. CAS No. 16290-26-9. Molecular formula: C7H10BrNO2. Mole weight: 220.07. Catalog: APB16290269. | |
| Ixazomib Impurity 13 | Ixazomib Impurity 13. Uses: For analytical and research use. Alternative Names: 2,5-dichloro-N-(2-(3-hydroxy-3-methylbutanamido)-2-oxoethyl)benzamide. Molecular formula: C14H16Cl2N2O4. Mole weight: 347.19. Catalog: APB02062. | |
| Ixazomib Impurity 13 | Ixazomib Impurity 13. Uses: For analytical and research use. CAS No. 6334-18-5. Molecular formula: C7H4Cl2O. Mole weight: 175.01. Catalog: APB6334185. | |
| Ixazomib Impurity 14 | Ixazomib Impurity 14. Uses: For analytical and research use. Alternative Names: 2,5-dichloro-N-(2-formamido-2-oxoethyl)benzamide. Molecular formula: C10H8Cl2N2O3. Mole weight: 275.09. Catalog: APB02174. | |
| Ixazomib Impurity 14 | Ixazomib Impurity 14. Uses: For analytical and research use. CAS No. 6287-38-3. Molecular formula: C7H4Cl2O. Mole weight: 175.01. Catalog: APB6287383. | |
| Ixazomib Impurity 15 | Ixazomib Impurity 15. Uses: For analytical and research use. CAS No. 10203-08-4. Molecular formula: C7H4Cl2O. Mole weight: 175.01. Catalog: APB10203084. | |
| Ixazomib Impurity 16 | Ixazomib Impurity 16. Uses: For analytical and research use. Alternative Names: methyl 2-(2,5-dichlorobenzamido)acetate. CAS No. 338965-44-9. Molecular formula: C10H9Cl2NO3. Mole weight: 262.09. Catalog: APB338965449. | |
| Ixazomib Impurity 17 | Ixazomib Impurity 17. Uses: For analytical and research use. CAS No. 349086-08-4. Molecular formula: C12H15Cl2NO. Mole weight: 260.16. Catalog: APB349086084. | |
| Ixazomib Impurity 18 | Ixazomib Impurity 18. Uses: For analytical and research use. CAS No. 328283-61-0. Molecular formula: C11H11Cl2NO3. Mole weight: 276.12. Catalog: APB328283610. | |
| Ixazomib Impurity 19 | Ixazomib Impurity 19. Uses: For analytical and research use. CAS No. 1239908-20-3. Molecular formula: C20H23BCl2N2O9. Mole weight: 517.12. Catalog: APB1239908203. | |
| Ixazomib Impurity 2 | Ixazomib Impurity 2. Uses: For analytical and research use. Alternative Names: N-(2-amino-2-oxoethyl)-2,5-dichlorobenzamide. CAS No. 1378314-08-9. Molecular formula: C9H8Cl2N2O2. Mole weight: 247.08. Catalog: APB1378314089. | |
| Ixazomib Impurity 20 | Ixazomib Impurity 20. Uses: For analytical and research use. CAS No. 1429055-05-9. Molecular formula: C14H16Cl2N2O2. Mole weight: 315.19. Catalog: APB1429055059. | |
| Ixazomib Impurity 21 | Ixazomib Impurity 21. Uses: For analytical and research use. CAS No. 54730-36-8. Molecular formula: C7H3Cl5. Mole weight: 264.35. Catalog: APB54730368. | |
| Ixazomib Impurity 22 | Ixazomib Impurity 22. Uses: For analytical and research use. CAS No. 10541-71-6. Molecular formula: C7H3Cl5. Mole weight: 264.35. Catalog: APB10541716. | |
| Ixazomib Impurity 23 | Ixazomib Impurity 23. Uses: For analytical and research use. Molecular formula: C14H16Cl2N2O2. Mole weight: 315.19. Catalog: APB10563. | |
| Ixazomib Impurity 24 | Ixazomib Impurity 24. Uses: For analytical and research use. CAS No. 50-82-8. Molecular formula: C7H3Cl3O2. Mole weight: 225.45. Catalog: APB50828. | |
| Ixazomib Impurity 25 | Ixazomib Impurity 25. Uses: For analytical and research use. Molecular formula: C14H8Cl4N2O4S. Mole weight: 442.09. Catalog: APB10564. | |
| Ixazomib Impurity 26 | Ixazomib Impurity 26. Uses: For analytical and research use. CAS No. 6660-65-7. Molecular formula: C8H4Cl2O4. Mole weight: 235.02. Catalog: APB6660657. | |
| Ixazomib Impurity 27 | Ixazomib Impurity 27. Uses: For analytical and research use. Alternative Names: (R)-(3-methyl-1-(2-(2,3,5-trichlorobenzamido)acetamido)butyl)boronic acid. Molecular formula: C14H18BCl3N2O4. Mole weight: 395.47. Catalog: APB02173. | |
| Ixazomib Impurity 28 | Ixazomib Impurity 28. Uses: For analytical and research use. Molecular formula: C20H23BCl2N2O9. Mole weight: 517.12. Catalog: APB10565. | |
| Ixazomib Impurity 29 | Ixazomib Impurity 29. Uses: For analytical and research use. Alternative Names: 2-(2,3,5-trichlorobenzamido)acetic acid. Molecular formula: C9H6Cl3NO3. Mole weight: 282.51. Catalog: APB02172. | |
| Ixazomib Impurity 3 | Ixazomib Impurity 3. Uses: For analytical and research use. Alternative Names: 2-(2-(2,5-dichlorobenzamido)acetamido)acetic acid. Molecular formula: C11H10Cl2N2O4. Mole weight: 305.11. Catalog: APB02178. | |
| Ixazomib Impurity 30 | Ixazomib Impurity 30. Uses: For analytical and research use. Alternative Names: (R)-2,2'-(2-(3-methyl-1-(2,3,5-trichlorobenzamido)butyl)-5-oxo-1,3,2-dioxaborolane-4,4-diyl)diacetic acid. Molecular formula: C18H19BCl3NO8. Mole weight: 494.52. Catalog: APB02171. | |
| Ixazomib Impurity 31 | Ixazomib Impurity 31. Uses: For analytical and research use. Alternative Names: (R)-(3-methyl-1-(2-(2,4,5-trichlorobenzamido)acetamido)butyl)boronic acid. Molecular formula: C14H18BCl3N2O4. Mole weight: 395.47. Catalog: APB02169. | |
Our database is helping our users find suppliers everyday.
